Today's Healthcare Pulse
Abridge teams with Eli Lilly and Nvidia to expand AI scribe platform
Abridge announced a strategic investment from Eli Lilly and a partnership with Nvidia to build a foundation model for clinical conversations. The collaboration aims to broaden Abridge’s AI‑scribe services across more health systems and integrate with payers. The company already supports over 300 health systems.
Also developing:
MAIA Therapeutics Targets 100 Patients in Phase 3 NSCLC Trial of Ateganosine
MAIA Therapeutics announced that its Phase 3 THIO-104 trial of ateganosine in third‑line non‑small cell lung cancer has dosed 29 patients across 34 sites and will aim for 100 enrollments by year‑end. The FDA granted Fast Track designation, positioning the trial for an interim survival analysis in 2027.
AstraZeneca to Pull Zoladex 3.6 Mg Hormone Implant From Australian PBS on Nov. 1, 2026
AstraZeneca announced it will discontinue the 3.6 mg Zoladex (goserelin) monthly implant in Australia, removing it from the Pharmaceutical Benefits Scheme and private prescriptions on Nov. 1, 2026. The move, driven by commercial reasons, leaves a gap for hormone‑receptor‑positive breast‑cancer and endometriosis...
FDA Accepts Pharming's Joenja Resubmission, Paving Way for Pediatric APDS Treatment
The U.S. FDA has accepted Pharming Group's supplemental New Drug Application to expand Joenja (leniolisib) to children aged 4 to 11 with activated PI3K‑δ syndrome. The agency set a PDUFA target decision date for fall 2026, moving the therapy closer...

Healio AI Partners with Holland Foundation for Sight Restoration
Healio AI announced a partnership with the Holland Foundation for Sight Restoration to embed the Cincinnati Protocol for stem‑cell transplantation into its AI knowledge base. The nonprofit will supply educational content on severe ocular surface disease, enhancing Healio AI’s repository...
World Blood Donor Day 2026: What’s New in Blood Screening and Matching
World Blood Donor Day 2026, themed “One Drop of Humanity. Give Blood. Save Lives,” spotlights the persistent gap between blood demand and voluntary donations. In the United States, roughly 29,000 units of red blood cells are needed every two seconds,...

Lawmakers Move to Require Chaperones for ‘Sensitive’ Appointments in Military Health System
House Armed Services Committee leaders voted unanimously to embed a chaperone requirement into the FY2027 National Defense Authorization Act. The amendment mandates a trained third party be present for any military health exam involving genitalia, rectum or female breasts, targeting...
UC San Diego’s Kumar Says Social Media Exposes Ransomware Impact That Breach Reports Miss
Deepak Kumar of UC San Diego demonstrated that Facebook and Reddit can surface the patient‑ and provider‑level fallout of hospital ransomware that traditional breach reports overlook. By mining roughly 4,000 hospital Facebook pages and 73 Reddit subreddits from 2018‑2024, his...

AMA Webinar Recording on Maternity Care Coding Changes Now Available
The American Medical Association (AMA) has released the recording of its June 2 webinar on the upcoming CPT 2027 maternity care coding overhaul, available to registered users. The session explains a shift from bundled maternity billing to an encounter‑based structure that separates...
The Rise of the Invisible Patient Experience
Health systems are abandoning the old mantra of adding more digital features and are instead aiming for an "invisible" patient experience where technology fades into the background. Leaders at UCHealth, MetroHealth, Johns Hopkins and Mayo Clinic argue that excellence is...

AHA, West Health Launch Learning Collaborative on Aging Care
The American Heart Association, together with West Health, has unveiled a six‑month learning collaborative titled “Adopting Digital Tools for Better Aging Care.” The program, housed within the West Health Accelerator, targets hospital and health‑system leaders to embed evidence‑based practices for...

CMS Releases Updated Report on Complaint Data, Enforcement Efforts
On June 15, the Centers for Medicare & Medicaid Services (CMS) released an updated report detailing complaint volumes and enforcement actions across Medicare and Medicaid programs. The report shows a 15% year‑over‑year increase in complaints, reaching roughly 1,200 in the...

Winona Launches Menopause Research Initiative
Winona, a menopause‑focused telehealth provider, announced the Winona Research Initiative to fund rapid‑cycle studies on midlife women’s health. Selected "Winona Scholars" receive a $3,000 stipend, conference support, mentorship and publication assistance for six‑to‑eight‑week projects. The program opens on a rolling...

House Appropriations Committee Releases FY 2027 Appropriations Bill
The House Appropriations Committee unveiled its FY 2027 appropriations bill, earmarking significant federal funding for health‑care initiatives. The package emphasizes behavioral health integration, reauthorizes the Rural Community Hospital Demonstration Program, and supports rural maternity bed guarantees. Parallel legislation includes the Transparency...

Contraline Secures $92.5M to Push Its Male Birth Control Candidates Forward
Contraline, a Virginia‑based biotech focused on male contraception, closed a $92.5 million Series B round, lifting its total capital to $127 million. The funding will primarily fuel Phase 3 trials for NES/T, a once‑daily topical gel, while its implantable ADAM product moves toward Phase 2...
Sri Lanka Nursing Home Worker Says a ‘Chained’ Patient Was Among 13 Fire Victims
A fire at an unregistered nursing home for mental health patients in western Sri Lanka killed 13 people, including a resident who had been chained. Staff said two patients were restrained; one was rescued after being untied. The blaze, likely...
IntraBio Announces Submission of Variation Application to the European Medicines Agency for AQNEURSA® for Ataxia-Telangiectasia
IntraBio Inc. submitted a variation application to the European Medicines Agency to expand AQNEURSA®’s label to include Ataxia‑Telangiectasia (A‑T). The filing marks the first EMA request for a therapy targeting this rare neurodegenerative disorder. In the United States, the company’s...
13 Recent Health System CIO Moves
Hospital and health‑system CIOs are experiencing a wave of moves, with new hires, promotions and retirements reshaping leadership across the United States. A 2024 WittKieffer survey found 53 % of healthcare CIOs have served three years or less, and only 39 %...
Judge Blocks Munson Healthcare’s Bid to Transfer Oracle Health Data Breach Lawsuits
A Michigan federal judge rejected Munson Healthcare’s request to move two class‑action data‑breach lawsuits to Missouri, where related Oracle Health cases are consolidated. Chief Judge Hala Jarbou found Munson’s Cerner contract insufficient to establish Missouri jurisdiction. The court also ordered...
Minnesota System Promotes COO to CEO
Ridgeview Health, a Waconia, Minnesota system, announced Ben Nielsen as its new president and chief executive officer, effective June 14. Nielsen succeeds Mike Phelps, who will retire on Jan. 2 but will remain through 2026 to aid the handoff. Nielsen brings...

DOJ Unveils State-Federal Partnership to Combat Health Care, Consumer Fraud
The U.S. Justice Department has inaugurated a state‑federal partnership to combat health‑care and consumer fraud, starting in Ohio with plans to replicate the model elsewhere. Ohio and Georgia are seeing a surge in new hospice providers, prompting the Centers for...

The Key to AI Cardiology Analytics Is Human Action
Modern cardiovascular information systems (CVIS) now embed AI analytics that quickly surface performance gaps and generate detailed dashboards. However, experts warn that AI can only point out problems; it cannot prescribe or execute solutions. Effective improvement requires multidisciplinary teams—physicians, nurses,...

Pharmaceutical Executive Daily: Supreme Court Unanimously Rules in Favor of Hikma Pharmaceuticals in Skinny Label Case
The U.S. Supreme Court issued a unanimous 9‑0 opinion reversing the Federal Circuit and holding that Amarin Pharma did not plausibly allege that Hikma Pharmaceuticals actively induced infringement of Vascepa’s patents through its skinny‑label generic. The decision reaffirms the Hatch‑Waxman...

Texas Children’s Hospital to Pay $10M as Part of Detransition Settlement
Texas Children’s Hospital agreed to a $10 million settlement with the Texas Attorney General that requires the creation of a detransition clinic and a "Potential Gender‑Affirming‑Care Patient List." The hospital has 90 days from an effective date to launch multidisciplinary services,...

Feds Seize McLaren, Bentley, 12 Other Luxury Cars in Raid Tied to Alleged $30 Million Medicaid Fraud
Federal agents in Ohio seized 14 high‑end vehicles—including a McLaren 570S and a Bentley Bentayga—worth roughly $800,000, alongside three bank accounts holding about $469,000. The assets are linked to an alleged $30 million Medicaid fraud scheme that involved falsified behavioral‑health services...
Alopecia in Gender-Diverse Patients: Beyond Cosmetics to Clinical Significance
A new narrative review in Dermatology and Therapy synthesizes data on androgenetic alopecia (AGA) in transgender and gender‑diverse (TGD) patients, highlighting markedly higher rates among trans men on testosterone and comparable rates in trans women to cis men. The analysis...
Hidden Fees and Compounding Interest Drive Medical Debt Higher Even After Payments
Medical debt is swelling beyond the amount borrowers think they owe. Researchers and advocates say hidden fees, compounding interest and ancillary costs such as missed work and transportation add up, making debt more expensive even when borrowers stay current on...
Roche Launches Bundibugyo Ebola PCR Test in Six Days Amid Outbreak
Roche announced that its TIB MOLBIOL unit produced a research‑use‑only PCR test for the Bundibugyo Ebola virus in just six days after the genome was published. The rapid assay, compatible with LightCycler and cobas platforms, aims to bolster laboratory response to...
SCHOTT Pharma Invests $60M in Expanded Vial Plant in Lebanon, PA to Bolster U.S. Drug Supply
SCHOTT Pharma inaugurated new glass‑vial production lines in Lebanon, Pennsylvania, backed by a $60 million BARDA investment. The expansion lifts core vial output and more than triples capacity for high‑value solutions, aiming to shore up domestic drug packaging amid recent shortages.
Biogen's Salanersen Wins FDA Breakthrough Therapy Designation for SMA
Biogen announced that the FDA has granted Breakthrough Therapy Designation to its antisense drug Salanersen for spinal muscular atrophy (SMA). The designation follows Phase 1b data showing motor‑function gains in children who previously received gene therapy. The move accelerates Biotech’s Phase 3...
IMUNON Raises $10 Million to Fund Phase 3 Ovarian Cancer Trial, Bolstering B2B Pharma Pipeline
IMUNON, Inc. announced a $10 million cash financing package that includes preferred stock and secured promissory notes to fund its pivotal Phase 3 OVATION 3 ovarian cancer trial. The capital infusion is aimed at expanding enrollment and positioning the company for deeper B2B...

FDA Approves Ranluspec as Biosimilar to Lucentis
The U.S. Food and Drug Administration has granted approval for Ranluspec, an interchangeable biosimilar of Lucentis, to treat vision‑threatening retinal diseases. The drug is available in both vial and prefilled‑syringe formats and is offered in 0.3 mg and 0.5 mg strengths. Ranluspec...

U.S. Supreme Court Sides with Generic Drug Maker for Severe Hypertriglyceridemia Agent Icosapent Ethyl
The U.S. Supreme Court rejected Amarin’s inducement claim against generic maker Hikma for the hypertriglyceridemia drug icosapent ethyl, finding the brand‑name company failed to allege more than a mere possibility of active encouragement. The Court held Hikma’s labeling complied with...

VITAS CEO: CMS’ National Moratorium Disappointing
VITAS Healthcare CEO Joel Wherley called the Centers for Medicare & Medicaid Services' six‑month national moratorium on hospice and home‑health enrollment disappointing, citing its broad‑brush approach. CMS launched the pause on May 13 to curb fraudulent operators, but industry leaders...
Texas City Launches Nurse Triage Program for some 911 Calls
Arlington, Texas, has launched a Nurse Navigation Program that connects certain non‑life‑threatening 911 callers with registered nurses. The pilot, begun at the end of May in partnership with American Medical Response, has transferred 80 calls, with roughly 20% resolved without...

Scientists Discover Why Ozempic May Not Work for some People
A decade‑long study led by Stanford Medicine identified genetic variants in the PAM enzyme that cause GLP‑1 resistance in about 10% of people with type 2 diabetes. Carriers of these variants have higher circulating GLP‑1 but a blunted glucose‑lowering response to...
Glooko Introduces the First and Only Pump Settings EHR Integration to Bring Insulin Pump Data Directly Into Clinical Workflows
Glooko announced the launch of its Insulin Pump Settings EHR Integration, a device‑agnostic feature that streams critical pump configuration data directly into electronic health record flowsheets. The integration consolidates up to 24 data points—basal rates, carb ratios, sensitivity factors and...
Olympus’ Keith Boettiger on Robotic GI Surgery Push
Olympus, the world’s largest endoscopy system provider, is expanding into robotic gastrointestinal surgery through its Swan Endosurgical platform and a distribution partnership with EndoRobotics. The company aims to democratize complex procedures such as endoscopic submucosal dissection (ESD) by integrating robotics...
Human‑augmented AI Screening Saves $1.3M, Adds 14.7 QALYs
A cost-effectiveness assessment of using AI in disease screening (modeling) "Implementing an annual ‘copilot’ strategy in all ages would save US$1.32 million while gaining 14.73 quality-adjusted life years over a lifetime [per 100,000 people]" "Our findings demonstrate the indispensable role of human...
CMS Contradicts Lawmakers' Promise to Shield Cancer Patients
Lawmakers promised cancer patients would be protected from Medicaid cuts. Now CMS says otherwise https://t.co/ssiinnHHWH via @statnews

Will New Reforms Fix the ‘Fundamentally Broken’ PBM System?
The Consolidated Appropriations Act of 2026 introduced the first federal reforms aimed at curbing pharmacy‑benefit manager (PBM) excesses. Starting in 2028, Medicare Part D plans will pay PBMs flat fees instead of a percentage of a drug’s list price, and all...

Are Vaccine-Preventable Diseases Really Exploding… or Are We Finally Looking?
The United States is reporting a measurable rise in measles (2,288 confirmed cases in 2025) and a six‑fold jump in pertussis cases compared with 2023, prompting concerns about declining vaccination coverage. Public‑health agencies attribute part of the surge to pockets...

The 72-Hour Hurdle: Faster Prior Authorization Is Exposing Healthcare’s Broken Billing Cycle
The CMS Interoperability & Prior Authorization Rule now forces payers and providers to make clinical decisions within 72 hours, dramatically speeding up prior‑authorization cycles. While approvals are arriving faster, the downstream billing, claims and payment processes remain entrenched in legacy,...
Mich. FD Explores Launching Its Own Ambulance Transport Service
The Cascade Fire Department in Michigan is studying a basic life support ambulance transport program to address a surge in low‑acuity medical calls, which now account for roughly one‑third of its 3,000 annual responses. The township board has approved development...

Mayo Owns the Model, Microsoft Owns the Pipes: What the Mayo Clinic and Microsoft Frontier Healthcare AI Deal Reveals
On June 2 2026 Mayo Clinic and Microsoft announced a strategic partnership to build a frontier AI model for healthcare. Mayo will own the model and its intellectual property, while Microsoft will deliver it through Azure AI Foundry APIs. The model draws...

Shifting Our Focus to Sample Sensitivity: The Metric That Deserves More Attention in Respiratory Care
The article argues that sample sensitivity—how well a collection method captures pathogens—should be a primary metric in respiratory diagnostics. It explains that the upper nasal cavity and sinuses hold the highest viral loads, making liquid‑based collection like nasal lavage up...
Mabwell Secures IND Clearance in China for 9MW5211 IBD Antibody
Mabwell announced that China’s National Medical Products Administration approved an IND for its antibody 9MW5211, allowing the first clinical trials of the drug in inflammatory bowel disease on the mainland. The clearance follows a U.S. FDA approval and positions the...
Quoin Secures Japan Orphan Drug Designation for QRX003 Targeting Netherton Syndrome
Quoin Pharmaceuticals announced that Japan's Ministry of Health, Labour and Welfare granted orphan drug designation to its QRX003 therapy for Netherton syndrome, promising up to a decade of market exclusivity. The move adds to QRX003’s U.S. pediatric rare‑disease and fast‑track...

Hospitals Are Leading Efforts to Make Healthcare More Affordable
Hospitals and health systems are accelerating programs that lower costs and expand access, from prevention and care‑coordination initiatives to hospital‑at‑home, telehealth and predictive analytics. At the same time, they face rising expenses—supplies, drugs and a workforce that now consumes about...
GE HealthCare Secures FDA Clearance for AI Radiation Therapy Planning Software
GE HealthCare announced FDA 510(k) clearance for its AI‑enabled auto‑contouring software MIM Contour ProtégéAI+ 2.0. The clearance paves the way for faster radiation‑therapy planning for the roughly 2 million U.S. patients treated each year, and introduces a Predetermined Change Control Plan to...

How a Simple Blood Test Could Help Detect Heart Damage During Breast Cancer Treatment
Researchers observed that cardiac troponin I levels and ECG abnormalities rise during breast‑cancer chemotherapy, suggesting a simple blood test could flag early heart stress. In a pilot study of 50 women receiving anthracyclines or trastuzumab, troponin spikes coincided with prolonged...